Gene expression and promoter polymorphisms of DNA methyltransferase 3 B in nasopharyngeal carcinomas in Taiwanese people : A case-control study
暂无分享,去创建一个
Kai-Ping Chang | S. Hao | N. Tsang | Yun-Shien Lee | M. Cheng | Yu-Liang Chang | Chia-Lung Tsai | Tzu-Hao Wang | Chun-Ting Liu | Ta-Jen Lee | C. Tsai
[1] Kai-Ping Chang,et al. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. , 2007, Oral oncology.
[2] H. Hsu,et al. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. , 2007, Lung cancer.
[3] Ying Liang,et al. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. , 2006, Cancer research.
[4] B. Goh,et al. Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma. , 2006, Anticancer research.
[5] S. Jang,et al. A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. , 2006, International journal of oncology.
[6] Kazuhiro Yoshida,et al. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. , 2005, Oncology reports.
[7] Yue Dai,et al. [The C46359T polymorphism of DNMT3B promoter gene and pathogenesis of acute leukemia]. , 2005, Zhonghua nei ke za zhi.
[8] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[9] J. Schlesselman,et al. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. , 2005, Oncology reports.
[10] W. Guo,et al. Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. , 2005, World journal of gastroenterology.
[11] J. Sham,et al. Nasopharyngeal carcinoma , 2005, The Lancet.
[12] Yidi Su,et al. Parallel minisequencing followed by multiplex matrix-assisted laser desorption/ionization mass spectrometry assay for β-thalassemia mutations , 2005, Journal of Human Genetics.
[13] N. Eberhardt,et al. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. , 2005, Gynecologic oncology.
[14] Y. Yuasa,et al. Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. , 2005, The Biochemical journal.
[15] I. Bièche,et al. Identification of a three-gene expression signature of poor-prognosis breast carcinoma , 2004, Molecular Cancer.
[16] J. Park,et al. DNMT3B polymorphisms and risk of primary lung cancer. , 2004, Carcinogenesis.
[17] D. Eccles,et al. The DNMT3B C→T promoter polymorphism and risk of breast cancer in a British population: a case-control study , 2004, Breast Cancer Research.
[18] Peter A. Jones,et al. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. , 2004, Molecular cancer research : MCR.
[19] Sebastian Böcker,et al. High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. , 2003, Genome research.
[20] I. Bièche,et al. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] T. Shibahara,et al. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. , 2003, International journal of oncology.
[22] K. Maruyama,et al. The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. , 2002, Biochimica et biophysica acta.
[23] Hongbing Shen,et al. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. , 2002, Cancer research.
[24] S. Hirohashi,et al. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] Yu-Sun Chang,et al. The Epstein–Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Kwong,et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. , 2001, Cancer research.
[27] T. Bestor,et al. The DNA methyltransferases of mammals. , 2000, Human molecular genetics.
[28] K. Hung,et al. A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. , 2000, Nucleic acids research.
[29] R. Momparler,et al. DNA methylation and cancer , 2000, Journal of cellular physiology.
[30] M. Hsu,et al. Nasopharyngeal carcinoma in Taiwan clinical manifestations and results of therapy , 1983, Cancer.
[31] P. Johnson,et al. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.